Ling Qi
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
CD30 CAR-T cells in combination with anti-PD-1 camrelizumab in relapsed/refractory CD30+ lymphomas.
Journal: Journal of translational medicine
Published: December 06, 2025
Application and Research Progress of Selinexor in Hematologic Tumors Other Than Multiple Myeloma --Review
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 27, 2024
Porcine Anti-Lymphocyte Globulin, Cyclosporine A Plus Thrombopoietin Receptor Agonists Achieved Similar Efficacy and Survival Compared to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Aplastic Anemia.
Journal: International journal of general medicine
Published: May 17, 2024
An important oversight in the World Health Organization diagnostic classification: chronic myeloid leukemia with the PML::RARA fusion clone.
Journal: Haematologica
Published: April 20, 2024
Efficacy and Survival of Venetoclax Based Regimen in the Treatment of Acute Myeloid Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: December 09, 2023
Efficacy and Safety of Flumatinib in Treatment of Patients with Chronic Myeloid Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 08, 2023
Longitudinal dynamics of gut microbiota in the pathogenesis of acute graft-versus-host disease.
Journal: Cancer medicine
Published: June 09, 2023
Efficacy and Safety of Dual-Targeting Chimeric Antigen Receptor-T Therapy for Relapsed or Refractory B Cell Lymphoid Malignancies: A Systematic Review and Meta-Analysis.
Journal: Human gene therapy
Published: February 03, 2023
Immunophenotype distinctions of CEBPA mutation subtypes in acute myeloid leukemia.
Journal: International journal of laboratory hematology
Published: January 13, 2023
Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-stimulating Factor Therapy for Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Retrospective Study from a Single-Center.
Journal: Current medical science
Published: November 26, 2022
CD5+ diffuse large B-cell lymphoma has heterogeneous clinical features and poor prognosis: a single-center retrospective study in China.
Journal: The Journal of international medical research
Published: September 16, 2022
Steroid-resistant intestinal aGVHD and refractory CMV and EBV infections complicated by haplo-HSCT were successfully rescued by FMT and CTL infusion.
Journal: The Journal of international medical research
Published: December 17, 2021
Last Updated: 09/26/2026